Search results
PTC Therapeutics Announces FDA Acceptance and Priority Review of the BLA for Upstaza™
FOX 23 News Albany· 15 hours agoPTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the FDA has accepted for filing the...
Earnings call: Aquestive Therapeutics highlights progress and outlook for 2024
Investing.com· 6 days agoThe company also raised over $75 million in new capital and saw an 8% increase in total revenues,...
BrainStorm Cell Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate...
WJTV Jackson· 6 hours agoBrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced financial ...
Earnings call: Iterum Therapeutics reports Q1 2024 financials, updates on Sulopenem By Investing.com
Investing.com· 1 day agoIterum Therapeutics (NASDAQ: NASDAQ:ITRM) has announced its financial results for the first quarter...
Earnings call: Liquidia Corporation eyes FDA nod for YUTREPIA By Investing.com
Investing.com· 8 hours agoThe company is optimistic about ...potential, estimating peak sales could reach $3 billion. Despite...
Lykos Therapeutics Announces FDA Advisory Committee Meeting to Review Investigational MDMA-Assisted...
Fairfield-Suisun Daily Republic· 1 week agoLykos Therapeutics (formerly MAPS Public Benefit Corporation) ("Lykos"), a company dedicated to transforming mental healthcare, announced that on June 4, 2024, the U.S. Food ...
PTC Therapeutics Gets FDA Priority Review of Upstaza Gene Therapy
Market Watch· 14 hours agoPTC Therapeutics has won U.S. Food and Drug Administration priority review for its application seeking approval of its Upstaza gene therapy for the treatment ...
Earnings call: Viridian Therapeutics reports robust progress in Q1 2024 By Investing.com
Investing.com· 5 days agoViridian Therapeutics (VRDN), a biotechnology company specializing in the treatment of thyroid eye...
Earnings call: Fulcrum Therapeutics partners with Sanofi on FSHD drug
Investing.com· 1 day agoFulcrum Therapeutics (ticker: NASDAQ: FULC ) has entered into a significant collaboration with...
Earnings call: Voyager Therapeutics advances Alzheimer's and gene therapy By Investing.com
Investing.com· 16 hours agoWith a partnership with Neurocrine (NASDAQ:NBIX) and a recent deal with Novartis (SIX:NOVN), Voyager...